choose content

Choose content

Enter keywords to create a newsletter
create account

Create account

Enter your registration information
set preferences

Set preferences

Set up your newsletter name, delivery and time zone preferences
Hint: Enter different keywords to generate new results.

Now you can:

  1. Search the news index.
  2. Browse more than 1 million newsletters by category.
  3. Use preset newsletters:
    • Truvada

Truvada Newsletter
  • Q2 2025: A recap of the top headlines and interviews 03 Jul 2025 18:40 GMT

    … infants. In the CLEVER trial, clesrovimab reduced medically attended lower respiratory infections … in both trials. The treatment demonstrated superiority over once-daily oral Truvada (F … 17, 2025, the FDA accepted the new drug application for epinephrine …

  • Optum Rx Eliminates Reauthorization on an Additional 60 Drugs 30 Jun 2025 21:20 GMT

    drugs that treat chronic conditions. The newly added medications include treatments … capsules, Eprontia, Elepsia XR • Antidepressants: Aplenzin, Forfivo XL, Bupropion XL … , Fenoglide, Fibricor • HIV: Descovy, Truvada, Vocabria, Selzentry, Sunlenca • Dry Eye …

  • The FDA Approved a Twice-Yearly HIV Drug, Will it Be Accessible? 30 Jun 2025 03:32 GMT

    … Oral PrEP In clinical trials, the Yeztugo injections were … daily oral PrEP medication, Truvada. The first trial resulted in zero … been significant advances in treatment, which have resulted in … Therefore, having coverage for this drug will be vital. However, …

  • Gilead Eyes HIV Market Domination With Twice-Yearly Yeztugo as GSK Trails 02 Jul 2025 04:07 GMT

    … of patients take Truvada, Gilead’s old PrEP drug, or generic … pools of patients the big biotech will target as it seeks … Day said. The new drug could improve treatment compliance, which O’Day … around 50% for daily pills. The HIV doctor expects Yeztugo to be …

  • Twice-yearly injection could transform HIV prevention efforts 03 Jul 2025 13:47 GMT

    … clinicals trials leading up to FDA approval of the medication. This … once-daily Truvada. The PURPOSE 2 clinical trial was designed … just leaving prison, receiving treatment for intravenous substance abuse, … protective properties of the drug are key, as people …

  • Analysis shows Yeztugo approval a ‘momentous step’ for HIV prevention 02 Jul 2025 17:17 GMT

    … . The drug will compete with Gilead’s own oral PrEP therapies – Truvada … HIV treatment space, as the FDA paused several clinical trials evaluating two drug candidates … now open for the prestigious Pharmaceutical Technology Excellence Awards - one …

  • US approves Gilead's twice-yearly injection to prevent HIV 01 Jul 2025 19:32 GMT

    … tempered by the drug';s cost. [AFP] Drugs to prevent … the daily oral pill Truvada. In the second trial, involving over 2 … rate, again surpassing Truvada. Reported side effects included … both trials were published in The New England Journal of Medicine, …

  • Twice Yearly HIV Prevention Shot, Yeztugo, May Face Access Hurdles 01 Jul 2025 16:37 GMT

    … for Gilead's lenacapavir drug trial. (AP Photo/ … cabotegravir) and once-daily pills which include Truvada (emtricitabine/tenofovir). … by the FDA in 2022 as a treatment for HIV … the commercial and public (Medicaid and Medicare) sectors to offer …

  • SCOTUS ruling paves smooth launch path for Gilead's long-acting PrEP med Yeztugo, analyst says 01 Jul 2025 16:49 GMT

    … oral PrEP drugs Truvada and Descovy, but the company just won FDA approval … . The company’s Advancing Access medication assistance program is set up … , driven by Descovy and HIV treatment Biktarvy.  Outside of the implications …

  • HIV prevention advances, but stigma persists 30 Jun 2025 17:06 GMT

    … antiretroviral drugs used to treat and prevent HIV. Truvada, one … of the most widely used prevention medications, must … around taking an HIV pill to prevent HIV,” she … inform patients about prevention and treatment options. (RHCJC News) Dr …

Satisfied with the content?

Continue to create your account.